Annual EBITDA
$13.59 M
-$9.55 M-41.27%
December 1, 2024
Summary
- As of March 10, 2025, UTMD annual EBITDA is $13.59 million, with the most recent change of -$9.55 million (-41.27%) on December 1, 2024.
- During the last 3 years, UTMD annual EBITDA has fallen by -$12.57 million (-48.04%).
- UTMD annual EBITDA is now -49.41% below its all-time high of $26.87 million, reached on December 31, 2022.
Performance
UTMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$2.93 M
-$1.15 M-28.24%
December 31, 2024
Summary
- As of March 10, 2025, UTMD quarterly EBITDA is $2.93 million, with the most recent change of -$1.15 million (-28.24%) on December 31, 2024.
- Over the past year, UTMD quarterly EBITDA has stayed the same.
- UTMD quarterly EBITDA is now -57.71% below its all-time high of $6.93 million, reached on September 30, 2021.
Performance
UTMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$16.45 M
-$2.05 M-11.10%
December 31, 2024
Summary
- As of March 10, 2025, UTMD TTM EBITDA is $16.45 million, with the most recent change of -$2.05 million (-11.10%) on December 31, 2024.
- Over the past year, UTMD TTM EBITDA has stayed the same.
- UTMD TTM EBITDA is now -39.40% below its all-time high of $27.15 million, reached on March 31, 2023.
Performance
UTMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
UTMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.3% | 0.0% | 0.0% |
| 3 y3 years | -48.0% | 0.0% | 0.0% |
| 5 y5 years | -44.5% | 0.0% | 0.0% |
UTMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -49.4% | at low | -57.5% | at low | -39.4% | at low |
| 5 y | 5-year | -49.4% | at low | -57.7% | at low | -39.4% | at low |
| alltime | all time | -49.4% | +1135.8% | -57.7% | +141.9% | -39.4% | +1595.8% |
Utah Medical Products EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $2.93 M(-28.2%) | $16.45 M(-11.1%) |
| Dec 2024 | $13.59 M(-41.3%) | - | - |
| Sep 2024 | - | $4.08 M(-1.2%) | $18.51 M(-8.3%) |
| Jun 2024 | - | $4.13 M(-22.2%) | $20.18 M(-9.3%) |
| Mar 2024 | - | $5.31 M(+6.5%) | $22.25 M(-5.5%) |
| Dec 2023 | $23.14 M(-13.9%) | $4.98 M(-13.4%) | $23.55 M(-7.2%) |
| Sep 2023 | - | $5.75 M(-7.3%) | $25.39 M(-4.3%) |
| Jun 2023 | - | $6.20 M(-6.2%) | $26.52 M(-2.3%) |
| Mar 2023 | - | $6.61 M(-3.1%) | $27.15 M(+1.0%) |
| Dec 2022 | $26.87 M(+2.7%) | $6.82 M(-0.9%) | $26.87 M(-0.3%) |
| Sep 2022 | - | $6.89 M(+0.8%) | $26.95 M(-0.2%) |
| Jun 2022 | - | $6.83 M(+7.9%) | $27.00 M(+0.8%) |
| Mar 2022 | - | $6.33 M(-8.3%) | $26.77 M(+2.3%) |
| Dec 2021 | $26.16 M(+25.1%) | $6.90 M(-0.4%) | $26.16 M(+3.2%) |
| Sep 2021 | - | $6.93 M(+4.8%) | $25.35 M(+6.5%) |
| Jun 2021 | - | $6.61 M(+15.4%) | $23.81 M(+13.6%) |
| Mar 2021 | - | $5.72 M(-6.0%) | $20.96 M(+0.2%) |
| Dec 2020 | $20.92 M(-14.7%) | $6.09 M(+13.0%) | $20.92 M(-1.9%) |
| Sep 2020 | - | $5.39 M(+43.4%) | $21.32 M(-3.5%) |
| Jun 2020 | - | $3.76 M(-33.8%) | $22.09 M(-10.3%) |
| Mar 2020 | - | $5.68 M(-12.6%) | $24.63 M(+0.5%) |
| Dec 2019 | $24.51 M(+13.2%) | $6.49 M(+5.4%) | $24.51 M(+6.6%) |
| Sep 2019 | - | $6.16 M(-2.1%) | $23.00 M(+4.7%) |
| Jun 2019 | - | $6.30 M(+13.2%) | $21.96 M(+2.3%) |
| Mar 2019 | - | $5.56 M(+11.6%) | $21.47 M(-0.8%) |
| Dec 2018 | $21.65 M(-0.6%) | $4.98 M(-2.6%) | $21.65 M(-1.4%) |
| Sep 2018 | - | $5.12 M(-11.9%) | $21.96 M(-1.2%) |
| Jun 2018 | - | $5.81 M(+1.2%) | $22.21 M(+0.4%) |
| Mar 2018 | - | $5.74 M(+8.5%) | $22.13 M(+1.6%) |
| Dec 2017 | $21.78 M(+14.5%) | $5.29 M(-1.6%) | $21.78 M(+4.8%) |
| Sep 2017 | - | $5.38 M(-6.0%) | $20.78 M(+3.7%) |
| Jun 2017 | - | $5.72 M(+6.0%) | $20.04 M(+3.5%) |
| Mar 2017 | - | $5.40 M(+25.9%) | $19.37 M(+1.8%) |
| Dec 2016 | $19.02 M(+1.4%) | $4.29 M(-7.3%) | $19.02 M(-1.4%) |
| Sep 2016 | - | $4.63 M(-8.4%) | $19.29 M(-0.9%) |
| Jun 2016 | - | $5.05 M(-0.0%) | $19.46 M(+1.6%) |
| Mar 2016 | - | $5.05 M(+11.0%) | $19.16 M(+2.1%) |
| Dec 2015 | $18.76 M(-3.6%) | $4.55 M(-5.1%) | $18.76 M(-2.4%) |
| Sep 2015 | - | $4.80 M(+1.0%) | $19.21 M(-0.3%) |
| Jun 2015 | - | $4.75 M(+2.1%) | $19.27 M(-0.8%) |
| Mar 2015 | - | $4.65 M(-7.2%) | $19.43 M(-0.1%) |
| Dec 2014 | $19.46 M(+7.4%) | $5.01 M(+3.3%) | $19.46 M(+2.9%) |
| Sep 2014 | - | $4.85 M(-1.2%) | $18.91 M(+2.1%) |
| Jun 2014 | - | $4.91 M(+4.9%) | $18.52 M(+2.3%) |
| Mar 2014 | - | $4.68 M(+4.8%) | $18.11 M(-0.0%) |
| Dec 2013 | $18.11 M(-1.9%) | $4.47 M(+0.2%) | $18.11 M(+0.5%) |
| Sep 2013 | - | $4.46 M(-1.0%) | $18.02 M(-1.7%) |
| Jun 2013 | - | $4.50 M(-3.9%) | $18.34 M(+0.7%) |
| Mar 2013 | - | $4.68 M(+7.0%) | $18.20 M(-1.4%) |
| Dec 2012 | $18.45 M(+25.4%) | $4.38 M(-8.3%) | $18.45 M(+3.1%) |
| Sep 2012 | - | $4.77 M(+9.2%) | $17.90 M(+2.3%) |
| Jun 2012 | - | $4.37 M(-11.4%) | $17.51 M(+1.6%) |
| Mar 2012 | - | $4.93 M(+29.1%) | $17.23 M(+17.1%) |
| Dec 2011 | $14.71 M(+52.1%) | $3.82 M(-12.7%) | $14.71 M(+10.0%) |
| Sep 2011 | - | $4.38 M(+7.0%) | $13.37 M(+17.3%) |
| Jun 2011 | - | $4.09 M(+68.9%) | $11.40 M(+18.1%) |
| Mar 2011 | - | $2.42 M(-2.5%) | $9.65 M(-0.2%) |
| Dec 2010 | $9.67 M(-5.3%) | $2.48 M(+3.2%) | $9.67 M(-2.5%) |
| Sep 2010 | - | $2.41 M(+2.7%) | $9.92 M(-1.2%) |
| Jun 2010 | - | $2.34 M(-4.0%) | $10.04 M(-0.1%) |
| Mar 2010 | - | $2.44 M(-10.6%) | $10.06 M(-1.6%) |
| Dec 2009 | $10.22 M(-11.6%) | $2.73 M(+7.9%) | $10.22 M(-2.0%) |
| Sep 2009 | - | $2.53 M(+7.3%) | $10.43 M(-5.1%) |
| Jun 2009 | - | $2.36 M(-9.4%) | $10.99 M(-4.3%) |
| Mar 2009 | - | $2.60 M(-11.6%) | $11.48 M(-0.7%) |
| Dec 2008 | $11.57 M(+1.9%) | $2.94 M(-4.8%) | $11.57 M(+1.4%) |
| Sep 2008 | - | $3.09 M(+8.5%) | $11.41 M(+2.0%) |
| Jun 2008 | - | $2.85 M(+6.0%) | $11.18 M(-0.2%) |
| Mar 2008 | - | $2.69 M(-3.4%) | $11.20 M(-1.4%) |
| Dec 2007 | $11.35 M(-1.0%) | $2.78 M(-2.8%) | $11.35 M(-1.0%) |
| Sep 2007 | - | $2.86 M(-0.2%) | $11.47 M(-0.3%) |
| Jun 2007 | - | $2.87 M(+0.9%) | $11.51 M(-0.1%) |
| Mar 2007 | - | $2.84 M(-2.0%) | $11.52 M(+0.5%) |
| Dec 2006 | $11.47 M | $2.90 M(+0.1%) | $11.47 M(+5.2%) |
| Sep 2006 | - | $2.90 M(+0.5%) | $10.91 M(+6.8%) |
| Jun 2006 | - | $2.88 M(+3.4%) | $10.21 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2006 | - | $2.79 M(+19.2%) | $9.97 M(+0.6%) |
| Dec 2005 | $9.91 M(-38.5%) | $2.34 M(+6.1%) | $9.91 M(+3.7%) |
| Sep 2005 | - | $2.20 M(-16.6%) | $9.56 M(-5.4%) |
| Jun 2005 | - | $2.64 M(-3.2%) | $10.10 M(-1.8%) |
| Mar 2005 | - | $2.73 M(+37.6%) | $10.29 M(-1.2%) |
| Dec 2004 | $16.13 M(+37.8%) | $1.98 M(-27.8%) | $10.42 M(-7.6%) |
| Sep 2004 | - | $2.75 M(-2.8%) | $11.27 M(-1.6%) |
| Jun 2004 | - | $2.83 M(-1.1%) | $11.46 M(-1.1%) |
| Mar 2004 | - | $2.86 M(+0.7%) | $11.59 M(-1.0%) |
| Dec 2003 | $11.71 M(-0.1%) | $2.84 M(-3.3%) | $11.71 M(-0.6%) |
| Sep 2003 | - | $2.94 M(-0.8%) | $11.78 M(-1.0%) |
| Jun 2003 | - | $2.96 M(-0.3%) | $11.90 M(+0.4%) |
| Mar 2003 | - | $2.97 M(+2.0%) | $11.85 M(+1.2%) |
| Dec 2002 | $11.71 M(+4.5%) | $2.91 M(-4.7%) | $11.71 M(+1.2%) |
| Sep 2002 | - | $3.06 M(+4.8%) | $11.57 M(+1.7%) |
| Jun 2002 | - | $2.92 M(+2.9%) | $11.39 M(+0.6%) |
| Mar 2002 | - | $2.83 M(+2.2%) | $11.32 M(+0.9%) |
| Dec 2001 | $11.21 M(+6.2%) | $2.77 M(-3.3%) | $11.21 M(+0.4%) |
| Sep 2001 | - | $2.87 M(+0.7%) | $11.17 M(+1.6%) |
| Jun 2001 | - | $2.85 M(+4.4%) | $11.00 M(+1.5%) |
| Mar 2001 | - | $2.73 M(-0.2%) | $10.83 M(+2.6%) |
| Dec 2000 | $10.56 M(+0.8%) | $2.73 M(+1.3%) | $10.56 M(-1.3%) |
| Sep 2000 | - | $2.69 M(+0.5%) | $10.70 M(-1.0%) |
| Jun 2000 | - | $2.68 M(+9.5%) | $10.80 M(+1.7%) |
| Mar 2000 | - | $2.45 M(-14.8%) | $10.62 M(+1.4%) |
| Dec 1999 | $10.47 M(+19.0%) | $2.87 M(+2.6%) | $10.47 M(+2.7%) |
| Sep 1999 | - | $2.80 M(+12.0%) | $10.20 M(+4.1%) |
| Jun 1999 | - | $2.50 M(+8.7%) | $9.80 M(+5.4%) |
| Mar 1999 | - | $2.30 M(-11.5%) | $9.30 M(+4.5%) |
| Dec 1998 | $8.80 M(+26.2%) | $2.60 M(+8.3%) | $8.90 M(+7.6%) |
| Sep 1998 | - | $2.40 M(+20.0%) | $8.27 M(+2.5%) |
| Jun 1998 | - | $2.00 M(+5.3%) | $8.07 M(+8.0%) |
| Mar 1998 | - | $1.90 M(-3.7%) | $7.47 M(+7.2%) |
| Dec 1997 | $6.97 M(-47.6%) | $1.97 M(-10.4%) | $6.97 M(-16.0%) |
| Sep 1997 | - | $2.20 M(+57.1%) | $8.30 M(-14.4%) |
| Jun 1997 | - | $1.40 M(0.0%) | $9.70 M(-17.8%) |
| Mar 1997 | - | $1.40 M(-57.6%) | $11.80 M(-12.6%) |
| Dec 1996 | $13.30 M(-0.7%) | $3.30 M(-8.3%) | $13.50 M(-2.2%) |
| Sep 1996 | - | $3.60 M(+2.9%) | $13.80 M(+1.5%) |
| Jun 1996 | - | $3.50 M(+12.9%) | $13.60 M(+1.5%) |
| Mar 1996 | - | $3.10 M(-13.9%) | $13.40 M(+0.8%) |
| Dec 1995 | $13.40 M(+18.6%) | $3.60 M(+5.9%) | $13.30 M(+5.6%) |
| Sep 1995 | - | $3.40 M(+3.0%) | $12.60 M(+4.1%) |
| Jun 1995 | - | $3.30 M(+10.0%) | $12.10 M(+4.3%) |
| Mar 1995 | - | $3.00 M(+3.4%) | $11.60 M(+2.7%) |
| Dec 1994 | $11.30 M(+14.1%) | $2.90 M(0.0%) | $11.30 M(+10.8%) |
| Sep 1994 | - | $2.90 M(+3.6%) | $10.20 M(+2.0%) |
| Jun 1994 | - | $2.80 M(+3.7%) | $10.00 M(-1.0%) |
| Mar 1994 | - | $2.70 M(+50.0%) | $10.10 M(+2.0%) |
| Dec 1993 | $9.90 M(-3.9%) | $1.80 M(-33.3%) | $9.90 M(-7.5%) |
| Sep 1993 | - | $2.70 M(-6.9%) | $10.70 M(-3.6%) |
| Jun 1993 | - | $2.90 M(+16.0%) | $11.10 M(+4.7%) |
| Mar 1993 | - | $2.50 M(-3.8%) | $10.60 M(+2.9%) |
| Dec 1992 | $10.30 M(+19.8%) | $2.60 M(-16.1%) | $10.30 M(+1.0%) |
| Sep 1992 | - | $3.10 M(+29.2%) | $10.20 M(+7.4%) |
| Jun 1992 | - | $2.40 M(+9.1%) | $9.50 M(+5.6%) |
| Mar 1992 | - | $2.20 M(-12.0%) | $9.00 M(+5.9%) |
| Dec 1991 | $8.60 M(+32.3%) | $2.50 M(+4.2%) | $8.50 M(+7.6%) |
| Sep 1991 | - | $2.40 M(+26.3%) | $7.90 M(+6.8%) |
| Jun 1991 | - | $1.90 M(+11.8%) | $7.40 M(+2.8%) |
| Mar 1991 | - | $1.70 M(-10.5%) | $7.20 M(+7.5%) |
| Dec 1990 | $6.50 M(+47.7%) | $1.90 M(0.0%) | $6.70 M(+4.7%) |
| Sep 1990 | - | $1.90 M(+11.8%) | $6.40 M(+10.3%) |
| Jun 1990 | - | $1.70 M(+41.7%) | $5.80 M(+18.4%) |
| Mar 1990 | - | $1.20 M(-25.0%) | $4.90 M(-34.7%) |
| Dec 1989 | $4.40 M(+69.2%) | $1.60 M(+23.1%) | $7.50 M(-781.8%) |
| Sep 1989 | - | $1.30 M(+62.5%) | -$1.10 M(-200.0%) |
| Jun 1989 | - | $800.00 K(-78.9%) | $1.10 M(-66.7%) |
| Mar 1989 | - | $3.80 M(-154.3%) | $3.30 M(+65.0%) |
| Dec 1988 | $2.60 M(+136.4%) | -$7.00 M(-300.0%) | $2.00 M(-54.5%) |
| Sep 1988 | - | $3.50 M(+16.7%) | $4.40 M(+57.1%) |
| Jun 1988 | - | $3.00 M(+20.0%) | $2.80 M(+86.7%) |
| Mar 1988 | - | $2.50 M(-154.3%) | $1.50 M(+114.3%) |
| Dec 1987 | $1.10 M | -$4.60 M(-342.1%) | $700.00 K(-86.8%) |
| Sep 1987 | - | $1.90 M(+11.8%) | $5.30 M(+55.9%) |
| Jun 1987 | - | $1.70 M(0.0%) | $3.40 M(+100.0%) |
| Mar 1987 | - | $1.70 M | $1.70 M |
FAQ
- What is Utah Medical Products annual EBITDA?
- What is the all time high annual EBITDA for Utah Medical Products?
- What is Utah Medical Products annual EBITDA year-on-year change?
- What is Utah Medical Products quarterly EBITDA?
- What is the all time high quarterly EBITDA for Utah Medical Products?
- What is Utah Medical Products quarterly EBITDA year-on-year change?
- What is Utah Medical Products TTM EBITDA?
- What is the all time high TTM EBITDA for Utah Medical Products?
- What is Utah Medical Products TTM EBITDA year-on-year change?
What is Utah Medical Products annual EBITDA?
The current annual EBITDA of UTMD is $13.59 M
What is the all time high annual EBITDA for Utah Medical Products?
Utah Medical Products all-time high annual EBITDA is $26.87 M
What is Utah Medical Products annual EBITDA year-on-year change?
Over the past year, UTMD annual EBITDA has changed by -$9.55 M (-41.27%)
What is Utah Medical Products quarterly EBITDA?
The current quarterly EBITDA of UTMD is $2.93 M
What is the all time high quarterly EBITDA for Utah Medical Products?
Utah Medical Products all-time high quarterly EBITDA is $6.93 M
What is Utah Medical Products quarterly EBITDA year-on-year change?
Over the past year, UTMD quarterly EBITDA has changed by $0.00 (0.00%)
What is Utah Medical Products TTM EBITDA?
The current TTM EBITDA of UTMD is $16.45 M
What is the all time high TTM EBITDA for Utah Medical Products?
Utah Medical Products all-time high TTM EBITDA is $27.15 M
What is Utah Medical Products TTM EBITDA year-on-year change?
Over the past year, UTMD TTM EBITDA has changed by $0.00 (0.00%)